arrow
L

Lennie Derde

Flinders University
H指数:41
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial

评估血浆铁蛋白和suPAR作为接受阿那白滞素治疗的危重症COVID-19患者的可治疗特征:REMAP-CAP随机临床试验免疫调节领域的探索性分析

2026-10-010
OAAI
Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial

COVID-19重症患者中的中剂量肝素血栓预防:一项随机临床试验

2026-07-012
OAAI
Gender equality and equity in intensive care: an international Delphi consensus study

重症监护中的性别平等与公平:一项国际德尔菲共识研究

2026-04-150
PRE
Determinants of diagnostic yield and scan quality of [18F]FDG PET/CT in critically ill patients suspected of infection or inflammation of unknown origin

[18F]FDG PET/CT在疑似感染或不明原因炎症的危重患者中的诊断率和扫描质量的决定因素

2026-04-100
OA
Community-acquired pneumonia

社区获得性肺炎

2025-10-160
PRE
The immunology of sepsis: translating new insights into clinical practice

脓毒症的免疫学:将新见解转化为临床实践

2025-09-240
PRE
Environmental sustainability in intensive care: the path forward. An ESICM Green Paper

重症监护中的环境可持续性: 前进的道路。ESICM绿皮书

2024-10-081
OAAI
The impact of the massive open online course C19_SPACE during the COVID-19 pandemic on clinical knowledge enhancement: a study among medical doctors and nurses

新型冠状病毒肺炎大流行期间大规模开放在线课程C19_SPACE对临床知识增强的影响: 医生和护士的研究

2024-09-300
PRE
Reframing sepsis immunobiology for translation: towards informative subtyping andtargeted immunomodulatory therapies

重新构建败血症免疫生物学以进行翻译: 迈向信息性亚型和靶向免疫调节疗法

2024-04-0117
OAAI